Articles

ASH 2023 Conference Round Up: CAR-T Cell Therapies Raise Safety Concerns While Progress In Combination Therapies Continues

Pharmaceuticals / United States / Thu 21 Dec, 2023

Key View

  • Safety concerns continue to be a major challenge for CAR-T therapies, potentially affecting future regulatory approvals and widespread clinical adoption.
  • Recent clinical data suggest a revival of AbbVie and J&J’s Imbruvica in mantle cell lymphoma, following an earlier withdrawal of the drug.
  • Seagen's Adcetris and Bristol Myers
Read More

Quick View: Moroccan Policy Rate On Hold In 2024

Country Risk / Morocco / Wed 20 Dec, 2023

Latest Development: As we had expected, Al Maghrib (BAM) kept its benchmark policy rate at 3.00% for the third consecutive quarter on 19 December. Meanwhile, on December 20, the Haut Commissariat Au Plan released figures showing that inflation decelerated from 4.3% y-o-y in October to 3.6% in November.

BAM Keeps Policy Rate On Hold
Moroc
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.